Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation.

Weijs B, de Vos CB, Tieleman RG, Peeters FE, Limantoro I, Kroon AA, Cheriex EC, Pisters R, Crijns HJ.

Europace. 2013 Jan;15(1):18-23. doi: 10.1093/europace/eus203. Epub 2012 Jul 10.

PMID:
22782972
2.

Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls.

Weijs B, Pisters R, Haest RJ, Kragten JA, Joosen IA, Versteylen M, Timmermans CC, Pison L, Blaauw Y, Hofstra L, Nieuwlaat R, Wildberger J, Crijns HJ.

Heart Rhythm. 2012 Dec;9(12):1923-9. doi: 10.1016/j.hrthm.2012.08.013. Epub 2012 Aug 8.

PMID:
22885921
3.

Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.

Winkel TA, Hoeks SE, Schouten O, Zeymer U, Limbourg T, Baumgartner I, Bhatt DL, Steg PG, Goto S, Röther J, Cacoub PP, Verhagen HJ, Bax JJ, Poldermans D.

Eur J Vasc Endovasc Surg. 2010 Jul;40(1):9-16. doi: 10.1016/j.ejvs.2010.03.003. Epub 2010 Apr 10.

4.

Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry.

Chiang CE, Naditch-Brûlé L, Murin J, Goethals M, Inoue H, O'Neill J, Silva-Cardoso J, Zharinov O, Gamra H, Alam S, Ponikowski P, Lewalter T, Rosenqvist M, Steg PG.

Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):632-9. doi: 10.1161/CIRCEP.112.970749. Epub 2012 Jul 11.

5.

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Kannel WB, Wolf PA, Benjamin EJ, Levy D.

Am J Cardiol. 1998 Oct 16;82(8A):2N-9N.

PMID:
9809895
6.

[Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].

Potpara T, Marinković-Erić J, Grujić M, Radojković-Cirović B, Vujisić-Tesić B, Petrović M.

Srp Arh Celok Lek. 2002 May-Jun;130(5-6):189-92. Serbian.

7.

Baseline characteristics of patients from Poland enrolled in the global registry of patients with recently diagnosed atrial fibrillation (RecordAF).

Opolski G, Kosior DA, Kurzelewski M, Skrzyńska M, Zagórski A, Janion M, Muzolf M, Wlazłowski R, Pankiewicz B, Łoboz-Grudzień K, Breithardt G; Polish RecordAF..

Kardiol Pol. 2010 May;68(5):546-54.

8.

Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.

Ahmari SA, Bunch TJ, Chandra A, Chandra V, Ujino K, Daly RC, Kushwaha SS, Edwards BS, Maalouf YF, Seward JB, McGregor CG, Chandrasekaran K.

J Heart Lung Transplant. 2006 Jan;25(1):53-60. Epub 2005 Nov 2.

PMID:
16399531
9.

Coronary surgery in patients with preexisting chronic atrial fibrillation: early and midterm clinical outcome.

Rogers CA, Angelini GD, Culliford LA, Capoun R, Ascione R.

Ann Thorac Surg. 2006 May;81(5):1676-82.

PMID:
16631655
10.

[The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].

De Sisti A, Leclercq JF, Fiorello P, Palamara A, Attuel P.

G Ital Cardiol. 1998 Nov;28(11):1253-60. Italian.

PMID:
9866803
11.

Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P; AFFIRM Investigators..

Am Heart J. 2005 Apr;149(4):657-63.

PMID:
15990749
12.

Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.

Disertori M, Lombardi F, Barlera S, Maggioni AP, Favero C, Franzosi MG, Lucci D, Staszewsky L, Fabbri G, Quintarelli S, Bianconi L, Latini R.

Am Heart J. 2011 Aug;162(2):382-9. doi: 10.1016/j.ahj.2011.05.008. Epub 2011 Jul 7.

PMID:
21835301
13.

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.

Goto S, Bhatt DL, Röther J, Alberts M, Hill MD, Ikeda Y, Uchiyama S, D'Agostino R, Ohman EM, Liau CS, Hirsch AT, Mas JL, Wilson PW, Corbalán R, Aichner F, Steg PG; REACH Registry Investigators..

Am Heart J. 2008 Nov;156(5):855-63, 863.e2. doi: 10.1016/j.ahj.2008.06.029. Epub 2008 Sep 23.

PMID:
19061698
14.

Preprocedural predictors of atrial fibrillation recurrence following pulmonary vein antrum isolation in patients with paroxysmal atrial fibrillation: long-term follow-up results.

Miyazaki S, Kuwahara T, Kobori A, Takahashi Y, Takei A, Sato A, Isobe M, Takahashi A.

J Cardiovasc Electrophysiol. 2011 Jun;22(6):621-5. doi: 10.1111/j.1540-8167.2010.01984.x. Epub 2011 Jan 14.

PMID:
21235666
15.

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

Maggioni AP, Latini R, Carson PE, Singh SN, Barlera S, Glazer R, Masson S, Cerè E, Tognoni G, Cohn JN; Val-HeFT Investigators..

Am Heart J. 2005 Mar;149(3):548-57.

PMID:
15864246
16.

Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.

Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, Boone J, Sheldon R, Dorian P, Newman D.

Am Heart J. 2005 Mar;149(3):489-96.

PMID:
15864238
17.

Percutaneous ablation of atrial fibrillation: assessment of outcomes at 1-year follow-up.

Adragão PP, Cavaco DM, Santos KR, Aguiar C, Raposo L, Morgado FB, Neves JP, Abecasis M, Chotalal D, Bonhorst D, Gomes RS.

Rev Port Cardiol. 2003 Nov;22(11):1301-8. English, Portuguese.

18.

Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, Williard A; ALLHAT Collaborative Research Group..

J Am Coll Cardiol. 2009 Nov 24;54(22):2023-31. doi: 10.1016/j.jacc.2009.08.020.

19.

Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece.

Tsagalis G, Bakirtzi N, Manios E, Chouliaras I, Papagiannidou P, Stamellou E, Akrivos T, Makris F, Psimenou E, Koutroubas G, Xinos K, Vemmos K.

Artif Organs. 2011 Oct;35(10):916-22. doi: 10.1111/j.1525-1594.2011.01229.x. Epub 2011 May 25.

PMID:
21615429
20.

[Mid-term clinical and prognostic evaluation of idiopathic atrial fibrillation].

Ciaroni S, Bloch A.

Arch Mal Coeur Vaiss. 1993 Jul;86(7):1025-30. French.

PMID:
8291937

Supplemental Content

Support Center